Gapping up
In reaction to strong earnings/guidance:
- HLIT +15.3%, (also Avid Tech announces a global patent cross-licensing agreement with Harmonic), UIS +10.7%, ALSN +8.2%, EXAS +7.8%, SNE +7.7%, APTI +6.9%, STRL +6.3%, CGNX +5.9%, (also announced that its quarterly dividend has been increased to $0.09 per share. The company's stock will undergo a 2-1 split and will begin trading on a split-adjusted basis on December 4), QNST +5.8%, MDLZ +5.3%, MRNS +4.9%, RCII +4.3%, (also to explore strategic and financial alternatives, suspends quarterly dividend; Chairman Steven Pepper resigns), MOS +4.3%, TREX +4.2%, RYAAY +4%, CMCO +4%, CRAY +3.4%, SHOP +3.3%, MDCA +3.1%, DAC +3%, RTTR +3%, WCG +2.8%, KAI +2.7%, BP +2.5%, INCY +2.4%, ETN +2.3%, BURL +2.2%, (expects Q3 EPS of $0.64-0.66, including $0.02 benefit from the recent accounting change for share-based compensation, vs $0.62 consensus; also sees comps approx. 3.1% vs guidance of 2-3% ), RDY +2.2%, BPMC +2.2%, CBI +2%, SBAC +1.9%, AET +1.8%, LMNX +1.7%, TCPC +1.3%, OSK +1.1%, NTLA +1.1%, NPO +1%
M&A news:
- NSM +5.9% (reports the company hired advisors for potential sale)
Other news:
- GERN +14.6% (FDA has granted Fast Track designation to imetelstat for the potential treatment of adult patients with transfusion-dependent anemia due to Low or Intermediate-1 risk myelodysplastic syndromes)
- MBVX +12.5% (provides update on MVT-5873 Phase 1 clinical program and expansion of preclinical development pipleline)
- SNGX +6% (discloses entry into a securities purchase agreement pursuant to which it agreed to issue and sell an aggregate of 1,575,500 shares of its common stock in a registered direct offering & private placement at $2.00)
- DBVT +2.6% (reports Q3 cash position)
- KTOS +1.3% (receives unmanned aerial drone system contract valued at $14.5 million)
- NVS +0.8% (submits application for Kymriah to FDA)
Analyst comments:
- NVAX +12.7% (upgraded to Buy from Neutral at Citigroup)
- ABB +2.2% (added to Conviction Buy List at Goldman)
- CRM +0.9% (initiated with a Buy at Guggenheim)
- CERN +0.8% (upgraded to Outperform from Neutral at Robert W. Baird)
Under Armour (-16%) at four-year low after missing on the top line and cutting earnings guidance in half (16.41)
NKE -2%, LULU -1%
Early premarket gappers
Gapping up:
- HLIT +15.3%, UIS +10.7%, EXAS +8.8%, ALSN +8.2%, NSM +6.9%, APTI+6.9%, SNE +6.8%, STRL +6.3%, MDLZ +5.8%, QNST +5.8%, RCII +4.3%,TREX +4.2%, RYAAY +4.1%, CGNX +4%, CMCO +4%, CRAY +3.4%, BURL+3.4%, MDCA +3.1%, DAC +3%, WCG +2.8%, KAI +2.7%, BP +2.4%, ETN+2.3%, RDY +2.2%, BPMC +2.2%, CBI +2%, INCY +2%, SBAC +1.9%, MOS+1.9%, LMNX +1.7%, AET +1.6%, PFE +1.6%, LODE +1.5%, DBVT +1.4%,TCPC +1.3%, S +1.1%, OSK +1.1%
Gapping down:
- UAA -13.4%, NLS -12.9%, LL -10.3%, VYGR -9.8%, SANM -8.5%, OHI -6.7%,MAC -6.4%, NR -5.9%, CMP -5.7%, TYPE -5.7%, SHOP -4%, CHGG -3.6%,KOS -3.4%, NVIV -3.4%, OFC -3.1%, OLN -2.6%, ELVT -2.4%, ADM -2.1%,AEIS -2%, IDXX -1.5%, CACC -1.4%, EIGI -1.2%, RTTR -1%, CG -0.9%
Gemalto, du Capitole à la roche tarpéienne (https://fr.wiktionary.org/wiki/il_n%E2%80%99y_a_pas_loin_du_Capitole_%C3%A0_la_roche_Tarp%C3%A9ienne)
Confronté à la faiblesse de ses marchés, le spécialiste de la carte à puce réduit les coûts et se
cherche un avenir.
En 2013, Gemalto entra dans le prestigieux club du CAC 40. Un couronnement pour le fabricant de
carte à puces né en 2006 du rapprochement d’Axalto et de Gemplus. Sécurité, plates-formes
logicielles, paiement mobile, Olivier Piou, l’artisan de la fusion avait fait feu de tout bois pour porter
le joyau technologique français sur des fonts baptismaux. Las, quatre ans plus tard, la potion est
amère. Le spécialiste des cartes SIM est sorti de l’indice phare de la Bourse de Paris en 2015, et a
enchaîné au cours de l’année écoulée quatre avertissements sur ses résultats. Son directeur
général, M. Piou, a soudainement rendu son tablier en 2016 (/economie/article/2016/04/06/gemalto-le-pdg-dufabricant-
francais-de-cartes-a-puce-s-efface_4896816_3234.html) pour devenir simple administrateur de la société.
Que s’est-il passé ? Son successeur, Philippe Vallée devait rencontrer Mounir Mahjoubi mardi
31 octobre. Au menu des discussions : l’identité numérique, l’un des chevaux de bataille de
Gemalto, qui fait aussi partie de la feuille de route du secrétaire d’Etat au numérique. Pourtant, dans
les couloirs de la société, il se murmure qu’une reprise de la société pourrait être évoquée dans le
bureau de M. Mahjoubi. Jusque-là, rien n’est venu étayer cette rumeur et de bonne source, la BPI,
qui possède 8 % du capital, espère être là sur le long terme.
Depuis que Gemalto ne tient plus ses promesses, les rumeurs vont bon train sur son avenir. Le
27 octobre, le fabricant d’électronique a réussi à calmer les inquiétudes. La société, qui a publié un
chiffre d’affaires stable à 751 millions d’euros au titre de son troisième trimestre, a maintenu ses
perspectives pour 2017, évitant un nouveau « profit warning ». Sur l’ensemble de l’exercice, la
société prévoit un bénéfice compris entre 293 et 323 millions d’euros.
Si Gemalto reste rentable, elle se situe loin des ambitions originelles de M. Piou, qui prédisait un
bénéfice de 660 millions d’euros cette année. Objectif qu’il s’est acharné à maintenir jusqu’à son
départ le 1er septembre 2016.
mobiles, et amenées à être remplacées par des e-Sim intégrées dans les appareils. « La vitesse de
décroissance du marché de la carte SIM a été plus rapide que prévue. C’est un marché qui va
disparaître à très long terme », admet M. Vallée. Au troisième trimestre, les ventes de cette activité
ont dégringolé de 12 %. L’ancien coeur d’activité de Gemalto ne pèse plus que 17 % du chiffre
d’affaires de la société. « En 2015, Olivier Piou disait que la carte SIM finirait par disparaître, mais
qu’il faudrait dix ans. Cela mettra moins de temps que ça », affirme Richard- Maxime Beaudoux,
analyste chez Bryan Garnier.
L’enjeu maintenant, réussir à prendre le prochain train de l’innovation. Car, si le principe de la SIM
continue d’exister, les fabricants de semi-conducteurs comme le groupe néerlandais NXP sont aussi
candidats pour équiper les nouveaux smartphones. « Une fois que la carte sera soudée dans le
téléphone voire dématérialisée, le groupe devra se concentrer sur les services [chargement de
données etc.] », indique l’analyste chez Bryan Garnier. Cette activité sera-t-elle toujours aussi
rentable pour Gemalto ? « Gemalto continuera d’intervenir auprès des opérateurs avec des
solutions de connectivité des objets », explique M. Vallée.
Second problème, les cartes bancaires à puces aux Etats-Unis. En retard, les Américains se sont
massivement équipés entre la mi-2014 et la mi-2016, avant de mettre un coup de frein à ces achats
massifs, le temps d’écouler les stocks. Résultat, pour Gemalto, l’activité paiement aux Etats-Unis a
reculé de 25 % au dernier trimestre. « Aux Etats Unis, à partir du moment où les stocks seront
résorbés, nous rentrerons dans un rythme de croisière », veut croire M. Vallée.
Pour compenser, la société s’est diversifiée dans les documents d’identité, la sécurité des
entreprises ou l’Internet des objets, mais ces nouveaux terrains de jeu ne parviennent pas à
compenser les vaches à lait du groupe. De tels problèmes auraient-ils pu être anticipés ? En
présentant son plan à 2017, M. Piou s’était montré très optimiste. « On ne croyait pas à ce plan.
Personne ne voyait comment il était possible de doubler le résultat opérationnel en trois ans »,
témoigne Anthony Vella, de la CFE-CGC.
Les syndicats craignent des coupes en France
Officiellement, si l’ancien directeur général a pris du champ, c’est pour laisser le temps à son
successeur d’élaborer le plan stratégique qui devait être présenté à l’automne. Las, M. Vallée a
reporté cette échéance au 13 mars 2018. En réalité, beaucoup soupçonnent l’ancien directeur
général d’avoir laissé la main pour ne pas porter le chapeau d’une dégringolade.
En attendant, un plan d’économie de 50 millions d’euros a été annoncé, sur lequel 15 millions
d’euros ont déjà été réalisés. Le groupe a procédé à plusieurs coupes chirurgicales, fermant un site
à Shanghaï de 160 personnes, un à Jacksonville aux Etats-Unis de 200 personnes, menant un plan
social sur 39 postes dans sa filiale Netsize en France. Reste 35 millions d’euros à trouver.
Les syndicats craignent maintenant des coupes en France, où Gemalto compte 2 800 salariés.
« Dans le Nord, le site de Pont-Audemer [Eure] est en danger depuis plusieurs années. Celui de
Tours [Indre-et-Loire] subit [aussi] des pressions », révèle un rapport d’expertise commandé par les
élus. « Un scénario plausible pourrait être le rapprochement de Tours et de Pont-Audemer, voire leur
disparition, ainsi que des coupes au siège social de Meudon [Hauts-de-Seine] », poursuivent les
experts. Gemalto conserve des doublons issus de la fusion des activités d’Axalto et de Gemplus,
alors qu’il possède aussi à l’étranger des sites identiques à ceux de la France. Le groupe
délocalisera-t-il ? Interrogé sur d’éventuelles économies dans l’Hexagone, M. Vallée répond
« qu’aucune décision n’est prise ». A ce stade.
Pfizer beats by $0.02, reports revs in-line; raises FY17 guidance slightly (35.15)
- Reports Q3 (Sep) earnings of $0.67 per share, excluding non-recurring items, $0.02 better than the Capital IQ Consensus of $0.65; revenues rose 0.9% year/year to $13.17 bln vs the $13.17 bln Capital IQ Consensus, reflecting operational growth of $178 million, or 1%, slightly offset by the unfavorable impact of foreign exchange of $54 million. Excluding the revenues for HIS in the prior-year quarter and the unfavorable impact of foreign exchange, third-quarter 2017 revenues increased by $458 million, or 4%.
- "Innovative Health revenues grew 11% operationally, primarily driven by the performance of our key growth drivers, notably Ibrance, Eliquis, Xtandi and Xeljanz, all of which are products that are early in their patent-protected lifecycle in attractive therapeutic areas. While Essential Health revenues remained challenged primarily due to continued headwinds from products that recently lost marketing exclusivity and product supply, we had solid operational growth in emerging markets and in biosimilars. "Looking ahead, we are encouraged by the convergence of two positive trends: an expected decline in the unfavorable revenue impact associated with product losses of exclusivity and the beginning of an expected multi-year wave of potential new product launches and product line extensions driven by our pipeline. We believe that the convergence of these trends, coupled with anticipated continued strong growth from the aforementioned innovative products, positions the Company for long-term success,"
- Co issues guidance for FY17, raises EPS to $2.58-2.62 from $2.54-2.60, excluding non-recurring items, vs. $2.56 Capital IQ Consensus Estimate; raises FY17 revs to $52.4-53.1 bln from $52.0-54.0 bln vs. $52.76 bln Capital IQ Consensus Estimate.
TOKYO, Oct. 31 (Yonhap) -- A tunnel under construction at North Korea's nuclear test site collapsed and as many as 200 workers could have been killed, a Japanese news report said Tuesday.
About 100 people were trapped inside when the unfinished tunnel at the North's Punggye-ri nuclear test site collapsed, and an additional 100 people could have been killed while trying to rescue those trapped as a second collapse occurred, Japan's TV Asahi reported.
The report didn't provide further details, such as when the accident happened.
Experts have warned that the North's nuclear test site must have become fatigued and unstable from six nuclear tests, including last month's latest and most powerful one, that a collapse could happen at any time.
On Monday, the chief of South Korea's weather agency Korea Meteorological Administration, Nam Jae-cheol, said during a parliamentary meeting that another nuclear blast could trigger a collapse of the North's mountainous test site and a leak of radioactive materials.
Dow -0.36% S&P -0.32% Nasdaq -0.03% Russell -1.15%
US MArket Closed lower. White House later said that President Trump does not support a phase-in approach, but equities continued trending sideways at session lows. Telecoms paced Monday's retreat after the Nikkei Asian Review reported that Sprint's parent company, SoftBank, plans to end merger talks between Sprint(-9.3%) and T-Mobile US(-5.4%). The two wireless names moved sharply lower following the report, but pared some of their losses after CNBC's David Faber said parts of the report were untrue. AAPL +3.2% after strong indication fo iPhone X demand. US after Hours CBI / MDLZ / ALSN / BURL +5% higher and NLS -10%, SANM -6% lower following earnings/guidance, NSM +6% on potential sale. Asian equity markets have opened generally lower, following the mixed trading session in the US. In the tech sector, chip giant, Samsung Electronics has gained over 1%. The company confirmed its Q3 results, announced a plan to increase capital returns to shareholders and said it plans to raise its FY17 Capex by over 80% y/y. Softbank has declined by over 5%, following the speculation that the merger between Sprint and T-Mobile could be canceled. Shares of Nintendo have risen by over 6%, as the company raised its FY forecast on demand for its Switch device.
Nikkei +0.00% HAng Seng -0.32% Shanghai +0.09% Shenzen +0.69%
Eur$ 1.1644 CNH 6.6274 CNY 6.6263 JPY 113.07 GBP 1.3208 CHF 0.9958 RUB 58.134 WTI$ 53.95 -0.37%
S&P +0.13% EuroStoxx +0.33% FTSE +0.29% Dax +0.03% SMI +0.21%
Macro :
- Pimco Quants Say Beware of Bond Hedges for High-Flying Stocks
- Electric Vehicles to Reach 5% Market Globally By 2022: Macquarie
Keep an eye on :
- AIR FP : Airbus 3Q Better Than Expected, FY Guidance Confirmed: Analysts
- AMUN FP : Amundi, Co-Investors Confirm La Defense Acquisition
- BNP FP : BNP 3Q Rev. Light; Focus on Weak Trading, Corporate Banking: MS
- CAP FP : Cap Gemini Says French Tech Startups Raised EU367M in 3Q
- CLLN LN : Carillion Sells Ask Real Estate Stake for GBP13.8m
- CRDA LN : Croda May See Slower Growth on Tougher 4Q Comps: Morgan Stanley
- DTE GY : SoftBank Doesn’t Have Plan to Withdraw From Sprint Talks: CNBC
- DUFN SW : Dufry 3Q Organic Growth 7.6%; No Decision Yet on Unit IPO
- EDPR PL : EDP Renovaveis Nine Month Net Income EU165 Mln
- ERF FP : Eurofins Selling 2.9% Stake for Balance Sheet Building, M&A
- IAG LN : IAG’s Walsh Sees Brexit Giving U.K. an Edge in Aviation Deals
- JE/ LN : Just Eat Boosts Full Year Revenue Forecast
- RYA LN : Ryanair 3Q Muted, Shows Some Signs of Recovery, Analysts Say
- NOKIA FH : Nokia, Ericsson to Benefit if Sprint/T-Mobile Talks End: Natixis
- OERL SW : Oerlikon 3Q Strong, Guidance Suggest Ests. Up 5%-10%: Baader
- SAN FP : Voyager Plunges After Sanofi Passes on Parkinson’s Option
- SIE GY : Siemens Is Said to Add BofA, BNP, Citi, UBS for Health Unit IPO
- TFI FP : TF1 3Q Sales Beat Estimates; Co. Confirms Outlook TF1 CFO Sees Still ’Limited’ Visibility on French Ad Market
- VOW3 GY : Bosch Loses Bid to Dismiss VW Dealers’ Diesel-Cheating Claims
- WEIR LN : Weir’s 3Q Margins Disappoint, Ebita Estimates Cut at Goldman
- ZC FP : Zodiac Profit Drops 19% on Seat Crisis; Sees Sharp Growth in ’18 Zodiac to ‘Re-Accelerate’ Retrofit of JetBlue’s A321 Cabins: CEO
>>> Up
* DS Smith Raised to Buy at Peel Hunt
* J. Martins Raised to Neutral at Natixis
* Segro Raised to Add at AlphaValue, PT 577p
>>> Down
* Castings Cut to Hold at Peel Hunt
* DKSH Cut to Reduce at Kepler Cheuvreux, PT CHF82
* DNB Cut to Hold at Norne Securities, PT NOK174
* Exprivia Cut to Neutral at Banca Akros
* Recticel Cut to Accumulate at KBC Securities
* Royal Mail Cut to Underperform at Credit Suisse
* Swiss Re Cut to Neutral at Goldman, PT CHF95
* Victrex Cut to Hold at Peel Hunt
* Wienerberger Cut to Hold at Raiffeisen Centrobank, PT EU23
* Xaar Cut to Add at Peel Hunt
>>> Initiation
* Amundi New Buy at Santander, PT EU82.80
* BC Vaudoise New Hold at Kepler Cheuvreux, PT CHF715
* Chemring Group New Add at Peel Hunt, PT 185p
* Deutsche Post New Buy at Berenberg, PT EU45
* DSV New Hold at Berenberg, PT DKK455
* Engie New Buy at Kepler Cheuvreux, PT EU16.50
* Gas Natural Resumed Hold at Deutsche Bank, PT EU19
* Grifols New Buy at Citi
* Kuehne + Nagel New Hold at Berenberg, PT CHF180
* Maersk New Sell at Berenberg, PT DKK10,000
* Royal Mail New Hold at Berenberg, PT 375p
* Switch New Market Perform at Raymond James
* Tyman New Buy at Peel Hunt, PT 430p
* Valiant New Reduce at Kepler Cheuvreux, PT CHF96
* VZ Holding New Buy at Kepler Cheuvreux, PT CHF380
>>> Call
Merrill
* GERMANY - Market is CLOSED today for Reformation Day Holiday.................
* AKER - $500m placing NOK155/shr; DNB/Danske/SEB. BAML UPGRADES to BUY this am
* EUROFINS - Selling 2.9% stake for balance sheet building; Jefferies/Berenberg
SCA - Beat with EBIT 18% ahead of cons and positive outlook commentary(80)+3-4%
RYANAIR - Better than expected with inline net profit & outlook unch (16.3).+3%
PLUS500 - Very strong numbers with third quarter revs at $116.5m (1026.4)...+3%
TELIA - Raises $1.03b by selling 19% remaining MegaFon bal at 514RUB (38).+1-2%
JUST EAT - Group order growth of 29% v cons at 22%.EBITDA guide unch (751)+1-2%
ASML - Sentiment positive that Samsung is raising its capex guidance (154)..+1%
DS SMITH - Positive qualitative trading statement; all inline with exp (521)+1%
CLARIANT - Sales and EBITDA both 4% ahead of cons. Outlook is unchanged (25)+1%
BP - Beat. NI $1.87b v cons $1.58b, DPS unch.To restart buyback program(507)+1%
CRODA - Sales cFX 4.4% in Q3 v 4% cons & strong perf in personal care (4014)u/c
LADBROKES - FOBT review.Govt launching consultation period with bookies(125)u/c
MERCK - Is said to start consumer unit disposal process; FT reports (91.9)..u/c
NOVARTIS - Submits application to FDA for KymriahTM in adult patients (81.6)u/c
WILLIAM HILL - Govt is launching a consultation period with the bookies(253)u/c
MINERS - Copper +0.18%, Iron Ore fut +0.4% & BHP OZ -0.34%, RIO OZ -0.76%.-0.5%
BNP - 2.5% rev miss driven by poor CIB likely to trigger profit taking (68).-1%
TDC - Broadly inline. Revs 1.4% miss but EBITDA a 0.5% beat v cons (37.6)...-1%
TRAVIS - Negative read from Geberit trimming guidance after 9 months (1515).-1%
GEBERIT - Trimmed FY guidance after 9 months from +3-4% growth to c.3% (468)-1%
WPP - Weak. Net sales -1.1% v cons -1.3%, PBIT margins were up +10bps (1282)-1%
AIRBUS - Revs +3.3% & EBIT +12.6% v cons. FCF before M&A ahead of ests(83)-1-2%
WEIR - Orders +21%,flow control -2% BUT looks like a 7% d/g to cons(1939)-5-10%
CS
Ageas +1% Positive read from China Taiping after numbers, have JV
Airbus UNCH Q3 Rev EU 14.24b est EU 14.13b, Guidance confirmed
Applus M/P 9 month revs $1185m vs cons 1189m, guidance unchanged
BNP Paribas -2% PBT 2% miss vs cons, French retail weak
BP +1-2% Adj net 1.87bn v street at $1.6bn
Clariant +0.5-1% Q3 4% beat on CSe & Cons. FY Guidance reiterated
Croda +1-2% Revs inline, Personal Care organic growth strong
Dufry R 9M revs CHF6.27b, 9M Ebitda margin 11.9%
DS Smith +1-2% Trading inline, ROACE in the upper end
Geberit -2% Adj Ebitda 2% below cons, Sales 733mln cons 735mln
Just Eat +1-2% Q3 total orders 43.1m vs cons 40.7m, raise to guidance
Miners UNCH Copper +0.25%, Brent +0.55%, Iron Ore +0.45%, China -0.10%
Oerlikon +2-3% Q3 orders 5% ahead of CS, sales 4% ahead
Roche M/P New data - etrolizumab can provide meaningful improvements
Royal Mail -1-2% CS DOWNGRADE to UNDERPERFORM (Worsening letter revs)
Ryanair +2-3% H1 net €1293m vs CS ests 1310m, guidance unchanged
SEB M/P 3Q sales inline with cons, confirms outlook
TDC M/P Q3 revenues meet estimates
Telia +1-2% Agreed to sell 19% holding of Megafon, SEK 8.6bln
TF1 +1-2% Revs 4% ahead, op profit also better
Weir -6-8% O&G +59% (we were looking for +80%), cuts FY guidance
WPP -1-2% Like for like rev growth weak
Zodiac M/P CS DOWNGRADE to NEUTRAL (Absance of upside)
Macq Indications:
UK:
* Bookies- No hard cut so small relief for high Street (LCL, WMH), Also the scrutiny of advertising will be -ve for PPB.
* BP- Starts buyback, Q3 Profit beats est’s. +2%
* Croda- Q3 sales +4.4% ccy, keeps FY outlook; +1%
* DS Smith- Positive outlook, trading inline. Unch
* Gem Diamonds- Diamond market remains strong, lowers FY ore treated but keeps carats recovered, operating costs +10%. -5%
* ITV- GfK consumer confidence for October declined again. -1%
* Kosmos- Hippocampe-1 Dry well. -2%
* Just Eat- Raising FY Rev Guidance from £500-515m to £515-530m, Retaining Ebitda guidance. +3%
* Petrofac- Kuwaiti Govt has resigned, also reporting the Jurassica Gas project is officially cancelled. PFC had pre-qualified for this. -2%
* Ryanair- FY guidance maintained, costs higher but well flagged. +1%
* Weir- Mineral profits slightly lower than expected due to project phasing, O&G and Control unchanged. Has had strong run.-5%
* WPP- Cuts FY Sales Forecast, has been flagged. -1-2%
MainFirst Pre Mkt Indications
*BNP-Q3 NI 2.04b(1.99),booked gain of 326m for India SBI Life.....-1%
*AIRBUS-Q3 Adj Ebit 697m(632.3),Rev 14.24b(14.13),outlook ok......+1% *TELIA-Sells Megafon stake to Gazprombank for about SK8.6b........+0.5%
*SEB-Q3 Rev 1.52b(1.52),Org Grth 8.8%(6.6%),Ebita 175m(180).......+0.5%
*RYANAIR-H1 Rev 4.43b(4.42),FY unch,Pilot costs add €100m.........+1%
*GEBERIT-Q3 Sales 733m(736.2),Ebit 179.5m(199),NI 158.5m(148).....-2% *DTE-Softbank calling off Sprint,T-Mobile talks Nikkei(denied)....Clsd
*CLARIANT-Q3 Sales 1.57b(1.49),Adj Ebitda 235m(225.9),o/l ok......+1% *SIEMENS-May list Health-Care Unit in Frankfurt first - BZ........Clsd
*DUFRY-Q3 Org Grth +7.6%(7),Ebitda 332m(333),GM 59.3%,FCF 337m....-0.5% *ZODIAC-FY NI 73.4m(107.3),FY Op Inc 218m(204.6),upbeat 2018......-0.5% *EUROFINS-ABB of 500k shares,via Berenberg & Jefferies at €543....-2%
*TF1-Q3 Rev 430m(413),co confirms guidance,visibility limited.....+0.5%
*OCERLIKON-Q3 Orders 739m(701),Sales 722m(696),Ebitda 112m(103)...+3%
*FEINTOOL-Q3 Sales 153.4m(151),Sys Parts 135.5m(132.5),o/lk ok....+1% *GRANDVISION-9M Sales 2.58b,Comp Sales +2.6%,Adj Ebitda 422m......-1%
*SCA-Q3 Net Sales 4.23b(4.03),Adj OP 776m(658.3),mkt conds ok.....+0.5%
*TDC-Q3 Ebitda 2.1b(2.07),Rev 4.96b(5.01),FY Ebitda 8.2b(8.29)....-0.5% *WPP-FY LFL Rev & Net Sales Grth flat(0%-1%),Q3 Rev 3.65b.........-3% *JUST EAT-Q3 Rev 138.6m,FY Rev 515-530m(515),Ebitda 157-163m(163).+2%